2m 2m 2m 2m 2m 2m 2m
Geron (GERN)
NASDAQ
$1.21$0.00 (0.00%)
Price as of Oct 02, 2026 5:07 PM EDT- $777.4MMarket Cap
- -12.32%1-Year Change
- BiotechnologyIndustry
Geron (GERN)
$1.21$0.00 (0.00%)
GERN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.21 | ||
Change | -$0.02 (-1.63%) | ||
Open | $1.24 | ||
High | $1.25 | ||
Low | $1.19 | ||
Previous Close | $1.23 | ||
Volume | 13,255,441 | ||
30-Day Average Volume | 11,697,821 | ||
1-Week Change | -3.97% | ||
1-Month Change | -18.24% | ||
1-Year Change | -12.32% | ||
3-Year Change | -42.92% | ||
5-Year Change | -12.32% | ||
Fundamentals | |||
Shares Outstanding | 642.5M | ||
Total Assets | $519.0M | ||
Market Cap | $777.4M | ||
Enterprise Value | $834.9M | ||
Period: QTR TTM FY | |||
Revenue | $57.5M | ||
Net Income | -$16.7M | ||
Free Cash Flow | -$15.8M | ||
EBIT | -$12.5M | ||
EBITDA | -$12.3M | ||
Net Working Capital | $416.0M | ||
EPS | -$0.02 | ||
Enterprise Value/EBITDA | -68 | ||
Enterprise Value/Revenue | 15 | ||
P/B | 4 | ||
P/E | -61 | ||
PEG | 1 | ||
Price/Free Cash Flow | -49 | ||
Price/Operating Cash Flow | -49 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue